ANALEPTIC PROPERTIES OF ROSUVASTATIN AND CQ10 COMBINATION
DOI:
https://doi.org/10.32553/ijmbs.v5i5.1918Keywords:
Rosuvastatin Ubiquinone, Cardiovascular, Dyslipidemia, IschemiaAbstract
This article is an examination of the Analeptic properties of Rosuvastatin and cq10 (Ubiquinone) combination. The scientific development and subsequent analysis of the ability of two combinational drugs Rosuvastatin and cq10 to treat human disorders/ diseases by lowering cholesterol and displaying antioxidant activity respectively, continues to influence researchers all over the globe, today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries demonstrates further aspects of Analeptic properties of Rosuvastatin and cq10 (Ubiquinone) combination. Additionally, this article explores options for Rosuvastatin and its effects on Dyslipidemia, glucose homeostasis and high-risk cardiovascular patients. This article also provides insights into Ubiquinone and its effects on cardiovascular diseases and hypertriglyceridemia. Lastly, from this article the combined effects of rosuvastatin and cq10 on cardiotoxicity, Ischemia and Induced Myopathy can also be gauged.
Keywords: Rosuvastatin Ubiquinone, Cardiovascular, Dyslipidemia, Ischemia
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International Journal of Medical and Biomedical Studies

This work is licensed under a Creative Commons Attribution 4.0 International License.
